Changzhou Qianhong Biopharma Co., Ltd. logo

Changzhou Qianhong Biopharma Co., Ltd. (002550)

Market Open
10 Aug, 06:57
XSHE XSHE
¥
6. 83
-0.21
-2.983%
¥
10.78B Market Cap
- P/E Ratio
0.48% Div Yield
36.9M Volume
- Eps
¥ 7.04
Previous Close
Add Transaction
Day Range
6.8 7.13
Year Range
5.58 11.53
Want to track 002550 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

002550 trading today lower at ¥6.83, a decrease of -2.983% from yesterday's close, completing a monthly increase of 10.1613% or ¥0.63. Over the past 12 months, 002550 stock lost -12.9936%.
002550 pays dividends to its shareholders, with the most recent payment made on May 29, 2026. The next estimated payment will be in In 9 months on May 29, 2027 for a total of ¥0.15.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0.1314%. On average, the company has surpassed earnings expectations by 0.0648%, based on the last three reports.
Changzhou Qianhong Biopharma Co., Ltd. has completed 3 stock splits, with the recent split occurring on May 31, 2016.
The company's stock is traded on one exchange.

002550 Chart

People also search for

Weichai Power Co., Ltd.
¥ 31.27
-2.5249%
Chongqing Changan Automobile Co., Ltd.
¥ 7.4
-0.2695%
Yunnan Baiyao Group Co., Ltd.
¥ 51.38
+0.3712%
Tianqi Lithium Corporation
¥ 48.24
-1.3699%
Guangzhou Tinci Materials Technology Co., Ltd.
¥ 39.6
-0.0505%

Changzhou Qianhong Biopharma Co., Ltd. (002550) FAQ

What is the stock price today?

The current price is ¥6.83.

On which exchange is it traded?

Changzhou Qianhong Biopharma Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 002550.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.48%.

What is its market cap?

As of today, the market cap is 10.78B.

Has Changzhou Qianhong Biopharma Co., Ltd. ever had a stock split?

Changzhou Qianhong Biopharma Co., Ltd. had 3 splits and the recent split was on May 31, 2016.

Changzhou Qianhong Biopharma Co., Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Ke Wang CEO
XSHE Exchange
CNE100001070 ISIN
China Country
979 Employees
29 May 2026 Last Dividend
31 May 2016 Last Split
18 Feb 2011 IPO Date

Overview

Changzhou Qianhong Biopharma CO., LTD is a prominent pharmaceutical company based in Changzhou, China. Established in 1971, the company has specialized in the manufacture and distribution of a wide range of pharmaceutical products, specifically focusing on polysaccharide and protease drugs. With a focus on high-quality standards, Changzhou Qianhong Biopharma has been serving the healthcare industry in China by providing an extensive portfolio of products, which includes tablets, hard capsules, lyophilized powder, lyophilized powder injections, small-volume injections, and raw materials. Moreover, the company has marked its global footprint by exporting its products, ensuring its presence in the international market and fulfilling the needs of patients worldwide.

Products and Services

Enzymes: The company has developed a solid reputation for its range of enzyme products, which play a crucial role in various medical treatments.

  • Pancreatic Kininogenase Series: A series of enzymes used for the treatment of cardiovascular diseases, providing relief and management through innovative enzyme technology.
  • Asparaginase Series: Focused on treating cancer, particularly leukemia, asparaginase helps to deplete the amino acid asparagine, crucial for cancer cells to thrive.
  • Compound Digestive Enzyme Capsule II: A digestive aid that combines several enzymes to improve digestive health, facilitating the breakdown and absorption of nutrients.

Polysaccharides Products: Changzhou Qianhong Biopharma also distinguishes itself in the field of polysaccharides, offering a variety of essential drugs.

  • Nadroparin Calcium: An anticoagulant used to prevent and treat deep vein thrombosis and pulmonary embolism, showcasing the company’s expertise in blood-related conditions.
  • Enoxaparin Sodium: Another vital anticoagulant, this low molecular weight heparin is used extensively in the prevention of blood clots.
  • Dalteparin Sodium: Similar in use to Enoxaparin Sodium, Dalteparin offers an alternative in the management and prevention of clotting disorders.
  • Asparaginase and Heparin Sodium Injections: Changzhou Qianhong Biopharma provides these injections for specialized treatments, reinforcing its capability in the production of critical care medications.

In addition to these, the company ensures the availability of such essential drugs in injection forms, catering to various medical needs and administration preferences.

Contact Information

Address: Life and Health Industrial Park
Phone: 86 519 8515 6026